The Effect of IV Ferric Carboxymaltose on Cardiac Reverse Remodelling Following CRT
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Effect of Intravenous Ferric Carboxymaltose on Cardiac Reverse Remodelling Following Cardiac Resynchronization Therapy - The IRON-CRT Trial
Eur Heart J 2021 Jun 29;[EPub Ahead of Print], P Martens, M Dupont, J Dauw, P Nijst, L Herbots, P Dendale, P Vandervoort, L Bruckers, WHW Tang, W MullensFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.